vs
CSW INDUSTRIALS, INC.（CSW）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
CSW INDUSTRIALS, INC.的季度营收约是REPLIGEN CORP的1.2倍（$233.0M vs $197.9M），REPLIGEN CORP净利率更高（6.7% vs 4.4%，领先2.3%），CSW INDUSTRIALS, INC.同比增速更快（20.3% vs 13.6%），CSW INDUSTRIALS, INC.自由现金流更多（$22.7M vs $17.6M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 5.1%）
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
CSW vs RGEN — 直观对比
营收规模更大
CSW
是对方的1.2倍
$197.9M
营收增速更快
CSW
高出6.7%
13.6%
净利率更高
RGEN
高出2.3%
4.4%
自由现金流更多
CSW
多$5.2M
$17.6M
两年增速更快
RGEN
近两年复合增速
5.1%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $233.0M | $197.9M |
| 净利润 | $10.3M | $13.3M |
| 毛利率 | 39.7% | 52.5% |
| 营业利润率 | 7.4% | 9.0% |
| 净利率 | 4.4% | 6.7% |
| 营收同比 | 20.3% | 13.6% |
| 净利润同比 | -61.9% | 143.9% |
| 每股收益（稀释后） | $0.62 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CSWRGEN
| Q4 25 | $233.0M | $197.9M | ||
| Q3 25 | $277.0M | $188.8M | ||
| Q2 25 | $263.6M | $182.4M | ||
| Q1 25 | $230.5M | $169.2M | ||
| Q4 24 | $193.6M | $174.1M | ||
| Q3 24 | $227.9M | $154.9M | ||
| Q2 24 | $226.2M | $154.1M | ||
| Q1 24 | $210.9M | $151.3M |
净利润CSWRGEN
| Q4 25 | $10.3M | $13.3M | ||
| Q3 25 | $40.7M | $14.9M | ||
| Q2 25 | $40.9M | $14.9M | ||
| Q1 25 | $35.1M | $5.8M | ||
| Q4 24 | $26.9M | $-30.3M | ||
| Q3 24 | $36.1M | $-654.0K | ||
| Q2 24 | $38.6M | $3.3M | ||
| Q1 24 | $31.8M | $2.1M |
毛利率CSWRGEN
| Q4 25 | 39.7% | 52.5% | ||
| Q3 25 | 43.0% | 53.2% | ||
| Q2 25 | 43.8% | 50.0% | ||
| Q1 25 | 44.2% | 53.6% | ||
| Q4 24 | 41.4% | 26.1% | ||
| Q3 24 | 45.6% | 50.0% | ||
| Q2 24 | 47.5% | 49.8% | ||
| Q1 24 | 44.4% | 49.5% |
营业利润率CSWRGEN
| Q4 25 | 7.4% | 9.0% | ||
| Q3 25 | 20.5% | 8.9% | ||
| Q2 25 | 20.8% | 7.6% | ||
| Q1 25 | 19.5% | 3.9% | ||
| Q4 24 | 15.3% | -17.7% | ||
| Q3 24 | 22.6% | -5.1% | ||
| Q2 24 | 24.3% | 1.0% | ||
| Q1 24 | 21.0% | 1.3% |
净利率CSWRGEN
| Q4 25 | 4.4% | 6.7% | ||
| Q3 25 | 14.7% | 7.9% | ||
| Q2 25 | 15.5% | 8.2% | ||
| Q1 25 | 15.2% | 3.4% | ||
| Q4 24 | 13.9% | -17.4% | ||
| Q3 24 | 15.8% | -0.4% | ||
| Q2 24 | 17.1% | 2.2% | ||
| Q1 24 | 15.1% | 1.4% |
每股收益（稀释后）CSWRGEN
| Q4 25 | $0.62 | $0.24 | ||
| Q3 25 | $2.41 | $0.26 | ||
| Q2 25 | $2.43 | $0.26 | ||
| Q1 25 | $2.05 | $0.10 | ||
| Q4 24 | $1.60 | $-0.55 | ||
| Q3 24 | $2.26 | $-0.01 | ||
| Q2 24 | $2.47 | $0.06 | ||
| Q1 24 | $2.03 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $40.2M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $1.1B | $2.1B |
| 总资产 | $2.3B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资CSWRGEN
| Q4 25 | $40.2M | $767.6M | ||
| Q3 25 | $31.5M | $748.7M | ||
| Q2 25 | $38.0M | $708.9M | ||
| Q1 25 | $225.8M | $697.2M | ||
| Q4 24 | $213.8M | $757.4M | ||
| Q3 24 | $273.2M | $784.0M | ||
| Q2 24 | $18.9M | $809.1M | ||
| Q1 24 | $22.2M | $780.6M |
总债务CSWRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | $800.1M | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $166.0M | — |
股东权益CSWRGEN
| Q4 25 | $1.1B | $2.1B | ||
| Q3 25 | $1.1B | $2.1B | ||
| Q2 25 | $1.1B | $2.1B | ||
| Q1 25 | $1.1B | $2.0B | ||
| Q4 24 | $1.0B | $2.0B | ||
| Q3 24 | $1.0B | $2.0B | ||
| Q2 24 | $650.2M | $2.0B | ||
| Q1 24 | $615.7M | $2.0B |
总资产CSWRGEN
| Q4 25 | $2.3B | $2.9B | ||
| Q3 25 | $1.5B | $2.9B | ||
| Q2 25 | $1.5B | $2.9B | ||
| Q1 25 | $1.4B | $2.9B | ||
| Q4 24 | $1.4B | $2.8B | ||
| Q3 24 | $1.4B | $2.8B | ||
| Q2 24 | $1.1B | $2.9B | ||
| Q1 24 | $1.0B | $2.8B |
负债/权益比CSWRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.27× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $28.9M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $22.7M | $17.6M |
| 自由现金流率自由现金流/营收 | 9.8% | 8.9% |
| 资本支出强度资本支出/营收 | 2.6% | 4.1% |
| 现金转化率经营现金流/净利润 | 2.81× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $162.0M | $93.9M |
8季度趋势，按日历期对齐
经营现金流CSWRGEN
| Q4 25 | $28.9M | $25.7M | ||
| Q3 25 | $61.8M | $48.1M | ||
| Q2 25 | $60.6M | $28.6M | ||
| Q1 25 | $27.3M | $15.0M | ||
| Q4 24 | $11.6M | $39.2M | ||
| Q3 24 | $66.8M | $49.3M | ||
| Q2 24 | $62.7M | $42.2M | ||
| Q1 24 | $22.4M | $44.7M |
自由现金流CSWRGEN
| Q4 25 | $22.7M | $17.6M | ||
| Q3 25 | $58.7M | $43.4M | ||
| Q2 25 | $57.7M | $21.5M | ||
| Q1 25 | $22.8M | $11.4M | ||
| Q4 24 | $8.5M | $33.6M | ||
| Q3 24 | $61.3M | $42.3M | ||
| Q2 24 | $59.6M | $37.4M | ||
| Q1 24 | $17.5M | $36.4M |
自由现金流率CSWRGEN
| Q4 25 | 9.8% | 8.9% | ||
| Q3 25 | 21.2% | 23.0% | ||
| Q2 25 | 21.9% | 11.8% | ||
| Q1 25 | 9.9% | 6.8% | ||
| Q4 24 | 4.4% | 19.3% | ||
| Q3 24 | 26.9% | 27.3% | ||
| Q2 24 | 26.3% | 24.3% | ||
| Q1 24 | 8.3% | 24.0% |
资本支出强度CSWRGEN
| Q4 25 | 2.6% | 4.1% | ||
| Q3 25 | 1.1% | 2.5% | ||
| Q2 25 | 1.1% | 3.9% | ||
| Q1 25 | 2.0% | 2.1% | ||
| Q4 24 | 1.6% | 3.2% | ||
| Q3 24 | 2.4% | 4.5% | ||
| Q2 24 | 1.4% | 3.1% | ||
| Q1 24 | 2.3% | 5.5% |
现金转化率CSWRGEN
| Q4 25 | 2.81× | 1.93× | ||
| Q3 25 | 1.52× | 3.23× | ||
| Q2 25 | 1.48× | 1.92× | ||
| Q1 25 | 0.78× | 2.57× | ||
| Q4 24 | 0.43× | — | ||
| Q3 24 | 1.85× | — | ||
| Q2 24 | 1.62× | 12.70× | ||
| Q1 24 | 0.71× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CSW
| Contractor Solutions Segment | $166.3M | 71% |
| Specialized Reliability Solutions Segment | $38.2M | 16% |
| Engineered Building Solutions Segment | $28.5M | 12% |
RGEN
暂无分部数据
